TE
VRTX icon

Tema ETFs’s Vertex Pharmaceuticals VRTX Stock Holding History

Tema ETFs’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.5M Sell
9,060
-580
-6% -$257K 0.15% 119
2026
Q1 		$4.3M Buy
9,640
+28
+0.3% +$13.1K 0.29% 89
2025
Q4 		$4.36M Sell
9,612
-39
-0.4% -$16.8K 0.34% 87
2025
Q3 		$3.78M Buy
9,651
+1,583
+20% +$662K 0.31% 96
2025
Q2 		$3.59M Sell
8,068
-380
-4% -$175K 0.95% 36
2025
Q1 		$4.1M Sell
8,448
-2,533
-23% -$1.18M 1.22% 20
2024
Q4 		$4.42M Buy
+10,981
New +$5.09M 1.84% 18

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Tema ETFs's VRTX Position: Q2 2026 in Review

Tema ETFs reduced its Vertex Pharmaceuticals (VRTX) stake by 6% in Q2 2026, selling an estimated $257K and leaving 9,060 shares worth $4.5M. The position accounts for 0.15% of the portfolio, ranked #119.

Tema ETFs first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 252 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Tema ETFs held 9,060 shares of Vertex Pharmaceuticals worth $4.5M as of Q2 2026.
  • Tema ETFs sold 580 Vertex Pharmaceuticals shares in Q2 2026, an estimated $257K.
  • Vertex Pharmaceuticals made up 0.15% of Tema ETFs's portfolio in Q2 2026, its #119 holding.
  • Tema ETFs first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 252 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.